Leveraging Radio-Imaging to Characterise ADC In-Human Tumour Targeting & Accelerate Therapeutic Development
- Utilising radio-binders to monitor tracking and delivery of cytotoxic and radio-conjugates, tailored to different payload types
- Delving into examples of radio-imaging to inform ADC target expression and PK/PD modelling
- Understanding enhanced properties of non-antibody conjugates for different approaches to conjugates therapeutics